BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
Vancouver, British Columbia--(. - September 17, 2026) - BetterLife Pharma Inc. CSE:BETR ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, is pleased to announce that it has closed its previously announced public offering (the "Of…
Story updates
02:41:41 PM UTC
SquawkNews
BetterLife Pharma closed a public offering raising approximately $100M via 447.0M shares at C$0.25 and 108.0M pre-funded warrants at C$0.24999; agents have a 15% over-allotment option.Material DetailsContext by AI AnalystThis is a major financing for a preclinical biotech to move BETR-001 into Phas…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.